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IT is now generally agreed that the unqualified diagnosis, "breast cancer"
embraces a wide spectrum of biological and clinical behaviour; and as earlier
concepts of the natural history of the disease come under critical scrutiny, the
prognostic indices have necessarily also to be re-appraised. The thesis of the
biological predeterminism of tumours (MacDonald, 1951)-that the outcome of
cancer in a particular patient is dictated essentially by the intrinsic malignancy of
the tumour in the environment in which it develops-does not exempt us from the
duty of re-examining all possible guides to the course of an individual lesion and
especially to its most effective therapeutic management.
It may well be in time that prognosis will be predictable with accuracy by
hormonal or immunological determinants. At present, however, we have come
to rely on less sophisticated criteria such as the size of the tumour, the presence
or absence of ominous local clinical signs, or more particularly on clinical staging.
It is our contention that a further parameter-the histological appearance of the
tumour-as an index of its malignancy has been insufficiently emphasised. This
study examines the validity ofthis view in relation to our own clinical experience.
HISTORICAL DEVELOPMENT
The histological grading oftumours is based on the concept that the malignancy
of a tumour must be related to its histological pattern. Von Hansemann is the
first to be credited with the suggestion in 1893 (Haagensen, 1933), but in fact
Dennis in the United States had previously observed such a relationship in 1891.
It was not until the early twenties that these observations were systematised.
Broders (1920) devised the first method of grading and his work was followed
by a series of papers further exploring the new technique. These have been well
documented by Bloom (1950).
Two distinct pathological features have been used to indicate malignancy and
therefore two techniques. Common to both was a study of the intimate features
ofindividual tumour cells and some methods ofgrading, including that ofBroders,
was based solely on this parameter, and of Greenough (1925) who first applied the
technique to breast cancer.
The interest of other early workers in this field (Sistrunk and MacCarty, 1922)
was concentrated on changes in the tumour stroma in terms of the connective
tissue element and lymphocyte content. This led to the development of a second
group of grading systems in which stromal factors, regarded as indicative of host
response, were assessed in conjunction with the cytological characteristics of the
tumour cells.
In this country the method used commonly in the study of breast cancer
belongs to the first group. It was devised by Scarff in 1928 (Patey and Scarff,GRADING IN BREAST CANCER
1928; Scarff and Handley, 1938), and subsequently used extensively by Bloom
(Bloom, 1950; Bloom and Richardson, 1957). Amongst modern examples of the
second group is the method ofHultborn and Tornberg (1960) in which lymphocytic
infiltration is regarded as the stromal event of importance.
Attempts to assess simultaneously both stromal and cellular factors are liable
to cause confusion since their biological significance is different. It has generally
been assumed that there is a broad relationship between the cellular characteristics
of a tumour and its intrinsic malignancy, while stromal factors are more likely to
be manifestations of a host defence mechanism. The effect on short term or long
term prognosis ofsuch a defence mechanism is at present unknown and elucidation
must await much further study. Eventually it may be that since cytologTical
characters and stromal response patterns are indications of different aspects of
tumour behaviour, both will be worthy of consideration.
In the present study we have adopted Scarff's method which is concerned
solely with cellular factors, is relatively simple, and involves the fewest unproven
assumptions. Briefly, the signs of a favourable prognosis are:
1. Well marked tubule formation.
2. Regularity in size, shape and staining of cells and nuclei.
3. The absence of hyperchromatic nuclei and scarcity of mitoses.
A score of 1 to 3 is given for each of these three features with an award of 3
representing the highest degree of malignancy. The scores for a given tumour are
then added together; a total of 3-5 allocating the case to Grade I, of 6-7 to Grade
II, while a total of 8-9 assigns the case to Grade III. The accompanying Fig. 1
to 6 illustrate some of the applications of the scoring system.
MATERIAL REVIEWED
The patients reviewed in this report are drawn from a series of 876 consecutive
cases of breast cancer admitted for primary treatment of their disease to certain
general surgical units in Edinburgh between January 1, 1946 and December 31,
1957. The fate of the entire series 10 years after initial treatment is known with
accuracy (Bruce et al., 1968). Histological tumour grading has been performed
on 687 cases of which 382 are now eligible for assessment 15 years after primary
treatment. The grading was carried out retrospectively by a single observer
unaware ofthe clinical staging or ofthe result oftreatment. The cases were staged
clinically (Table I) according to the Manchester classification (1946).
TABLE I. Distribution by Stayes (687 Graded Cases)
.Manchester Classification (1946)
Stage Number of cases
I 268
II 188
III . 70
IV 161
Treatment for the most part consisted ofsimple mastectomy and radical radio-
therapy. In a few patients this " standard" policy was modified; the modifica-
tions included simple mastectomy alone or with palliative radiotherapy, radical
mastectomy and, in a few, radiotherapy alone.
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RESULTS
Distribution ofgrades
The distribution of histological grades and the type of treatment employed in
the 687 cases are demonstrated in Table II.
TABLE II.-Methods ofTreatment Employed in 687 Histologically Graded Cases
Simple mastectomy and
radiotherapy
Number
of cases Percentage
53 11
258 51
191 38
502 100
Other methods of
treatment
Number
of cases Percentage
21
97
67
185
11
52
36
-100
Stage and grade
Since clinical staging is generally regarded as the most reliable guide to prog-
nosis, the relationship between histological grade and stage is important. It is
apparent (Table III) that the two are not necessarily related.
TABLE III.-Stage and Grade
Percentage of cases in each
histological grade
Clinical stage
I
II
III
IV
All stages
I
15
10
11
4
11
II
54
48
59
48
52
III
31
41
30
47
37
EXPLANATION OF PLATES
FIG. 1. Tubuleformation. Widespread tubule formation of this type is given a score of 1.
x 130.
FIG. 2.-Tubuleformation. The tubules inthis tumour are lesswell formed and fewer in number
than those illustrated in Fig. 1. The score allocated to this factor was 2. x 130.
FIG. 3. Nuclear characteristics. Note the uniformity of the nuclei, the infrequency of
hyperchromatism and the absence of mitotic figures. Such a tumour is rated a score of 1
both in respect of nuclear pleomorphism and of hyperchromatism and mitosis. x 595.
FIG. 4. Nuclear characteristics. Pleomorphism in this tumour is of an intermediate degree,
cf. Fig. 3 and 6. There is also a moderate degree of hyperchromatism. Both these charac-
teristics were allocated a score of 2. x 540.
FIG. 5.-Nuclear characteri8tic8. Note the wide range of nuclear size and shape and the
presence of a number of multinucleate giant cells. A score of 3 was allotted to nuclear
pleomorphism in this tumour. x 450.
FIG. 6.-Nuclear characteristics. In this tumour the nuclei showed considerable variation in
size and numerous mitotic figures several of which are present in this field. Both these
characteristics were allotted a score of 3. x 450.
Histological
grade
I
II
III
Totals
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TABLE IV.-Survival Rates by Grade (All Cases)
Grade I
A
Total Survival
cases Survivors rate (%)
74 55 74
74 37 50
45 14 31
Grade II
Total Survival
cases Survivors rate (%)
355 168 47
355 103 29
208 38 18
Grade III
Total Survival
cases Survivors rate (%)
258 90 35
258 64 25
129 33 26
Grade andprognosis
The 5 and 10-year survival rates are expressed in Table IV, and the survival
figures at 15 years are included for comparison. Since the distribution of grades
appears largely unaffected by clinical stages, one might expect the correlation
between the grade and prognosis to remain unaltered by staging. This is con-
firmed in Fig. 7.
5-YEAR
SURVIVAL
RATE
0/0
60r
10-YEAR 50
SURVI\AL
RATE 40
30
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10
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I
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STAGE I STAGE II STAGE III STAGE IV
FIG. 7. Grade, stage and prognosis-687 cases. (The numerals at the top of each
column indicate the histological grade.)
Length
of
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Age and grade
The effect ofage on the distribution ofhistological grade is indicated in Table V.
Comparison with Table II shows that the pattern ofgrade distribution in patients
over the age of45 at the time ofprimary treatment is similar to the overall pattern.
In younger patients, however, the relative proportions of Grade II and III appear
reversed, so that tumours in the higher grade predominate in this age group.
TABLE V.-Age and Grade
Age at Number of Percentage ofcases in each grade
primary treatment cases ,_A_ _
I II III
45 or under . 140 . 11 40 49
46-60 . . . 252 . 11 53 36
over 60 . . . 295 . 11 56 33
Relation to treatment
Of the 687 graded cases, 502 were treated by simple mastectomy and radical
radiotherapy. The survival rates within the various grades for patients treated
by this method are shown in Table VI.
TABLE VI.-Grade and Prognosis in 502 Patients Treated by
Simple Mastectomy and, Radiotherapy
Percentage survival rate in
each grade
, ~ ~ ~~A
Follow-up period I II III
5 years . . 81 56 42
10 years . 57 35 30
15 years . . 42 23 31
DISCUSSION
From its inception, histological grading has not lacked critics. Willis (1967)
regarded it as fallacious; " an arbitrary process conferring an entirely spurious
impression of precision ". No protagonist of grading has claimed or would claim
that it has mathematical accuracy but we believe that it provides a relatively
simple mneans of tabulating certain of the histological features of tumours, which
may then be correlated with the clinical behaviour pattern.
In an assessment ofthe value ofhistological grading it is important to establish
initially that tumour grade is independent of stage and then to decide how
accurately the histological appearance reflects the intrinsic malignanev of the
tumour. Table III expresses the breakdown ofthe series by grade and stage, and
it is apparent that despite some variation the relative proportions of cases within
each grade is independent of the clinical stage. Thus grading does not appear to
be a reflection of staging and can therefore be considered as an independent
criterion. The apparently high proportion of Grade III tumours in Stage IV is
interesting but as an isolated observation it does not influence any overall con-
clusion.
It can also be inferred that since tumour grade appears to remain unaltered
although the disease progresses to a more advanced stage, grade is a constant
property of the tumour. This contention is supported by the work of Bloom and
298GRADING IN BREAST CANCER-
Richardson (1957) who observed a reasonably constant histological appearance in
tissue removed from a primary tumour and from metastases occurring 10 or more
years after radical mastectomy.
It would be tempting to assume that the histological grade reflects closelv the
biologic predeterminism of a given tumour. Unfortunately, there may be little
correlation between histopathology and " doubling times " (Gershon-Cohen et al.,
1963) and grading cannot be considered as a comprehensive indication of biologic
predeterminism. Furthermore, the particular method of grading used in this
series purposely avoids all consideration of factors which might reflect the host
response and so might indicate a defensive or immunological reaction. A re-
stricted grading of this type can only express one side of the relationship between
tumour and patient, and because of the need to consider the all important time
factor, it should not be regarded as an independent parameter oftumour behaviour
and should be considered in combination with other factors such as clinical staging
and tumour size.
However, there is undoubtedly a good broad correlation between grade and
prognosis (Table IV). This is in accordance with Bloom's experience (1965) in a
series of 1411 cases, but whereas in our series the survival rates of patients in
Grades II and III tend to approximate once 10 years have elapsed, no such
phenomenon occurs in his series. It is possible that as the numbers in this series
approach those of Bloom the discrepancy will disappear, but it is also conceivable
that the definition ofthree grades is impracticable, and that the method would be
of greater value if only two categorieswereutilised, e.g. " well differentiated " and
"not well differentiated ". It is a fair criticism of this method that the majority
of cases were allocated to Grade II while fewer cases appeared " sufficiently malig-
nant " to enter Grade III, and even fewer appeared " sufficiently innocuous " to
enter Grade I.
It is not our intention to recommend an alteration in the system of grading as
we have insufficient evidence to suggest an alternative. One must remember,
however, that the three grades used by Scarffare purely arbitrary and there must
inevitably be some lack of sharp definition between them.
A further criticism of grading relates to the significance of sampling error but
in practice this is not insurmountable. A histological variation of sufficient
degree to render grading impossible occurred in only 1% of our series. It is
possible that a method which includes a consideration of the stroma may be more
subject to this error but the general experience in other series which have utilised
cytohistological features is comparable to our own (Patey and Scarff, 1928;
Haagensen, 1933; Bloom, 1950).
When the effect ofgrade and clinical stage are taken together and expressed in
terms of survival rate there is the expected broad correlation with prognosis
(Fig. 7). Unfortunately, the number of cases ascribed to Grade I is small and
any further subdivision renders assessment difficult. However, there is no doubt
that the results indicate a tendency for patients in the favourable grades and stages
to do better than their less fortunate counterparts, both criteria appearing to act
independently. The approximation of survival rates in Grades II and III noticed
in the earlier figures is again apparent at 10 years. The figures agree with those
of Bloom (1965) who observes good initial correlation, but even in his series there
is the same situation in terms of survival in Grades II and III when subdivided
into stages, whilst Grade I is always distinctive.
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All things considered, we believe that tumour grading has a definite place in
the assessment of breast cancer, but it must be considered in its true perspective.
It may not be an accurate independent reflection of the biologic predeterminism
ofa tumour, but when it is taken in conjunction with other factors, grading allows
a more refined assessment to be made.
The simultaneous assessment of a number of variables is the best prognostic
index available to us at the present time in the absence of direct methods capable
of determining the intrinsic malignancy of a tumour. AMyers et al. (1966) intro-
duced a scheme which considers four variables; size of primary, axillary node
involvement, histological grade of the tumour and sinus histiocytosis of axillary
nodes. It is of interest that they only applied the term " favourable " or " un-
favourable " to each criterion and by the use ofexponential functions and factorial
analysis they described the separate influences of each criterion on survival rates.
Berg and Robbins (1967) used three of the criteria (excluding sinus histiocytosis)
with the same application, " favourable " or " unfavourable ". By the use of a
mathematical model both authors predict the survival rates for the patients
analysed and achieve correlation with the observed survival rates. As Berg
himself points out, however, there are fallacies in oversimplicity and this may be
the case if one extrapolates beyond one set of observations, either further in time
or to other dissimilar groups of patients.
However, these models do represent a valid attempt to overcome the contem-
porary limitations in the assessment of prognosis in breast cancer. If their
significance is appreciated, they may well together constitute an index, the use of
which could go some way to overcome our present prognostic difficulties.
CONCLUSIONS
Our understanding of breast cancer is far from complete and no effort should
be spared in our attempts to assess the basic intrinsic malignancy ofthe individual
tumour. Ideally, no consideration of this problem should be limited to an
appraisal ofthe tumour alone, for such an approach is artificial and has the effect
of removing the tumour from the context of its host, the body.
While accepting the limitations ofthe criteria at our disposal for measuring the
intrinsic malignancy ofa breast carcinoma we can nevertheless attempt an indirect
approach by a summation of these criteria. Clinical stage and tumour size alone
are very coarse indices but by adding the factor of the histological grade of a
tumour one can achieve a more comprehensive assessment.
It is possible that modified grading systems may ultimately prove to be of
value as a means of selection of cases for treatment, but an extensive prospective
study in the light of our present knowledge will be required to substantiate this.
It can at least be said that where a study of the results of treatment of breast
cancer is intended, tumour grading should be a routine procedure.
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